Results 201 to 210 of about 1,113,140 (269)

Inhibitory effect of [6]-shogaol against 3CLpro activity and SARS-CoV-2 infection. [PDF]

open access: yesBMC Complement Med Ther
Tanikawa T   +5 more
europepmc   +1 more source

Targeting transcription factors associated with hemoglobinopathies: Lessons from successful interventions and implications for cancer

open access: yesMolecular Oncology, EarlyView.
This review summarizes the transcription factors, repressive chromatin‐modifying complexes, and epigenetic mechanisms that control fetal hemoglobin repression. Notably, many regulators of γ‐globin silencing also function in transcriptional and epigenetic networks that drive cancer, highlighting opportunities to translate advances in hemoglobinopathy ...
Meigen Yu   +3 more
wiley   +1 more source

Research on the inhibitory effect of hydrogen gas on ovarian cancer and potential mechanisms. [PDF]

open access: yesEur J Med Res
Yin M   +11 more
europepmc   +1 more source

Interferon beta drives therapy resistance in a patient‐derived model of high‐grade serous ovarian cancer

open access: yesMolecular Oncology, EarlyView.
Interferon type 1 (IFN‐1) production and signaling is associated with the acquisition of therapy resistance, following chronic DNA damage, via Interferon‐related DNA damage resistance signature (IRDS) gene expression. An alternative, DNA damage‐independent role of sustained IFN‐1 mediated resistance was identified and characterized by the emergence of ...
Ashlyn Conant   +11 more
wiley   +1 more source

CEACAM1 participation in breast cancer progression

open access: yesMolecular Oncology, EarlyView.
In invasive breast cancer (BC), CEACAM1 shifts from an apical to a uniform membranous/cytoplasmic pattern, or is lost, as tumors dedifferentiate, inversely tracking the Ki‐67 proliferative index. In MCF‐7 cells, only CEACAM1‐4L suppresses proliferation, repressing cell cycle and growth factor genes.
Mykola Lyndin   +3 more
wiley   +1 more source

The inhibitory effect and targets of CRM197 on tumor growth in arsenic-transformed cells and lung cancer cells. [PDF]

open access: yesSci Rep
Zhang X   +9 more
europepmc   +1 more source

Correction: Inhibitory effect of [6]-shogaol against 3CLpro activity and SARS-CoV-2 infection. [PDF]

open access: yesBMC Complement Med Ther
Tanikawa T   +5 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy